Does oral intake of thin fluids increase aspiration pneumonia for dysphagia after head and neck cancer surgery? A retrospective study for a total of 654 cases.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 22 09 2022
revised: 24 11 2022
accepted: 11 01 2023
medline: 17 7 2023
pubmed: 13 2 2023
entrez: 12 2 2023
Statut: ppublish

Résumé

Head and neck cancer (HNC) treatment causes dysphagia, which may lead to aspiration pneumonia (AP). Thickened fluids are widely used to prevent aspiration in patients with dysphagia; however, there is little evidence that they can prevent AP. This study aimed to clarify the differences between restriction of oral intake of fluids (R), only thickened fluids (TF), and no restriction of fluids (NR) for AP in patients with dysphagia after HNC treatment. We retrospectively studied 654 patients with dysphagia after HNC surgery between 2012 and 2021. Of these, 255 had some restriction of fluids. The development of possible AP and administration of antibacterial drugs were used as outcomes. Multivariate linear regression and propensity score matching analyses were performed. The mean patient age was 64 ± 13, 67 ± 11, and 68 ± 10 years, while the Dynamic Imaging Grade of Swallowing Toxicity score 3-4 was 2.8%, 27.5, and 53.3%% water in NR, TF, and R groups, respectively. AP was diagnosed or suspected after starting oral intake in 37 (9.3%), 11 patients (15.9%), and 45 (17.6%) and antibacterial drugs were administered in 11 (2.8%), 7 patients (10.1%), and 25 (9.8%) in NR, TF, and R groups, respectively. R and TF had significant negative impacts on AP. Fluid restrictions may not reduce the risk of AP or affect the administration of antibacterial drugs. Medical staff should bear in mind that fluid restrictions do not necessarily prevent AP in patients with HNC.

Identifiants

pubmed: 36775772
pii: S0385-8146(23)00027-5
doi: 10.1016/j.anl.2023.01.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

757-764

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Auteurs

Nao Hashida (N)

Department of Rehabilitation, Osaka International Cancer Institute, Osaka City, Japan. 3-1-69, Otemae, Chuo-ku, Osaka City, 541-8567, Japan; Swallowing Center, Osaka University Hospital, Osaka City, Japan. 2-15, Yamadaoka, Suita city, Osaka, 554-0871, Japan. Electronic address: nhashida@ent.med.osaka-u.ac.jp.

Hironari Tamiya (H)

Department of Rehabilitation, Osaka International Cancer Institute, Osaka City, Japan. 3-1-69, Otemae, Chuo-ku, Osaka City, 541-8567, Japan.

Mizuki Korematsu (M)

Department of Head and Neck Surgery, Osaka International Cancer Institute, Osaka City, Japan. 3-1-69, Otemae, Chuo-ku, Osaka City, 541-8567, Japan.

Takashi Fujii (T)

Department of Head and Neck Surgery, Osaka International Cancer Institute, Osaka City, Japan. 3-1-69, Otemae, Chuo-ku, Osaka City, 541-8567, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH